Why the study?
The study was conducted to describe the outcome of a case of severe drug-resistant fetal tachyarrhythmia with progressive hydrops treated with fetoscopic transesophageal pacing.
Does fetoscopic transesophageal pacing improve outcomes in fetuses with severe drug-resistant tachyarrhythmia and progressive hydrops?
Does fetoscopic transesophageal pacing improve outcomes in fetuses with severe drug-resistant tachyarrhythmia and progressive hydrops?
Fetoscopic transesophageal pacing may serve as a successful rescue therapy for severe drug-resistant fetal tachyarrhythmia complicated by progressive hydrops.
Suggests possible rescue role for fetoscopic pacing in refractory fetal tachyarrhythmia with hydrops; leaves open need for prospective validation.
Objective To describe the outcome of a case of severe drug‐resistant fetal tachyarrhythmia with progressive hydrops treated with fetoscopic transesophageal pacing (FTEP). Method A case of fetal tachyarrhythmia complicated by progressive hydrops is presented. The fetus, diagnosed at 26 +2 weeks of gestation, had supraventricular tachycardia with a mechanism suggestive of atrial reentry. Maternal treatment included digoxin, sotalol and amiodarone, which were ineffective in controlling the arrhythmia. After failure of pharmacological therapy, FTEP was performed. Results A male baby was delivered by cesarean section, with the Apgar scores of 10 at 1 min, 5 and 10 min at 35 +2 weeks of gestation. An initial neonatal electrocardiogram demonstrated normal sinus rhythm. Follow‐up is now up to 1 year, without tachyarrhythmia or cardiac dysfunction. Conclusion FTEP offers a potential rescue therapy for cases of severe drug‐resistant fetal tachyarrhythmia associated with progressive fetal hydrops and cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: